Perspective Therapeutics Inc (CATX)
1.58
-0.02
(-1.25%)
USD |
NYAM |
Apr 26, 16:00
1.59
+0.01
(+0.63%)
After-Hours: 20:00
Perspective Therapeutics Research and Development Expense (Quarterly): 6.08M for Dec. 31, 2023
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 6.08M |
| September 30, 2023 | 5.721M |
| June 30, 2023 | 5.653M |
| March 31, 2023 | 3.857M |
| September 30, 2022 | 0.708M |
| June 30, 2022 | 0.796M |
| March 31, 2022 | 0.549M |
| December 31, 2021 | 0.535M |
| September 30, 2021 | 0.702M |
| June 30, 2021 | 0.468M |
| March 31, 2021 | 0.362M |
| December 31, 2020 | 0.285M |
| September 30, 2020 | 0.312M |
| June 30, 2020 | 0.322M |
| March 31, 2020 | 0.294M |
| December 31, 2019 | 0.277M |
| September 30, 2019 | 0.233M |
| June 30, 2019 | 0.341M |
| March 31, 2019 | 0.299M |
| December 31, 2018 | 0.414M |
| September 30, 2018 | 0.42M |
| June 30, 2018 | 0.572M |
| March 31, 2018 | 0.473M |
| December 31, 2017 | 0.34M |
| September 30, 2017 | 0.362M |
| Date | Value |
|---|---|
| June 30, 2017 | 0.316M |
| March 31, 2017 | 0.327M |
| December 31, 2016 | 0.15M |
| September 30, 2016 | 0.172M |
| June 30, 2016 | 0.143M |
| March 31, 2016 | 0.183M |
| December 31, 2015 | 0.058M |
| September 30, 2015 | 0.144M |
| June 30, 2015 | 0.1564M |
| March 31, 2015 | 0.1414M |
| December 31, 2014 | 0.1406M |
| September 30, 2014 | 0.1766M |
| June 30, 2014 | 0.1982M |
| March 31, 2014 | 0.1536M |
| December 31, 2013 | 0.17M |
| September 30, 2013 | 0.147M |
| June 30, 2013 | 0.1813M |
| March 31, 2013 | 0.1551M |
| December 31, 2012 | 0.1492M |
| September 30, 2012 | 0.1415M |
| June 30, 2012 | 0.2074M |
| March 31, 2012 | 0.1322M |
| December 31, 2011 | 0.1897M |
| September 30, 2011 | 0.2013M |
| June 30, 2011 | 0.297M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
0.233M
Minimum
Sep 2019
6.08M
Maximum
Dec 2023
1.528M
Average
0.5015M
Median
Research and Development Expense (Quarterly) Benchmarks
| Retractable Technologies Inc | 0.1617M |
| InfuSystems Holdings Inc | -- |
| Xtant Medical Holdings Inc | 0.492M |
| Asensus Surgical Inc | 8.614M |
| Catheter Precision Inc | -0.011M |